(Q36717625)

15 August 2017

1 reference

title

Case management of malaria in pregnancy (English)

1 reference

pregnancy-associated malaria

15 August 2017

0 references

0 references

1 reference

1

1 reference

15 August 2017

2

Rose McGready

1 reference

15 August 2017

3

Theonest Mutabingwa

1 reference

15 August 2017

1 February 2007

1 reference

Lancet Infectious Diseases

15 August 2017

1 reference

15 August 2017

7

1 reference

15 August 2017

118-125

1 reference

15 August 2017

2

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

15 August 2017

1 reference

7 January 2021

Malaria as a cause of severe anaemia in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Malaria during pregnancy in an area of unstable endemicity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Effectiveness of antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Effects of Plasmodium vivax malaria in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Chloroquine resistance in Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: A study of one hundred thirty‐three cases compared with a control group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Antimalarial drugs in pregnancy: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Can amodiaquine be used safely during pregnancy?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Genotoxic evaluation of the antimalarial drug, fansidar, in cultured human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Antimalarial Drug Toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

A randomized controlled trial of folate supplementation when treating malaria in pregnancy with sulfadoxine-pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Clindamycin as an antimalarial drug: review of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Erythromycin and clindamycin absorption and elimination in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Quinine and mefloquine in the treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Artemether in the treatment of falciparum malaria during pregnancy in eastern Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Artesunate plus sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria during pregnancy in eastern Sudan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Randomised trial of artemether versus artemether and mefloquine for the treatment of chloroquine/sufadoxine-pyrimethamine-resistant falciparum malaria during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

The effects of mefloquine treatment in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Quinine and severe falciparum malaria in late pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Total dose iron infusion, malaria and pregnancy in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Haematinic treatment of anaemia increases the risk of Plasmodium vivax malaria in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

The effects of iron supplementation during pregnancy, given by traditional birth attendants, on the prevalence of anaemia and malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

The response to iron supplementation of pregnant women with the haemoglobin genotype AA or AS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Anthelminthic treatment and haemoglobin concentrations during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

Quinine pharmacokinetics and toxicity in pregnant and lactating women with falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970023-3

7 January 2021

10.1016/S1473-3099(07)70023-3

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17251082